Healthcare Nov 28, 2021 05:38 PM (GMT+8) · EqualOcean
Financial Associated Press, November 28 - East China Pharmaceutical announced that recently, the company's wholly-owned subsidiary, Sino US East China, received a notice from the U.S. FDA. The brief application for a new drug for daptomycin for injection (anda) declared by Sino US East China to the U.S. FDA has been approved.